TABLE 5.
Sensitivity and specificity of DNA‐ICM for lung cancer based on a literature review
| First author | Year | No. of patients | Specimen type | Sensitivity | Specificity |
|---|---|---|---|---|---|
| Marek W 29 | 1999 | 142 patients with suspected lung cancer and 50 controls (COPD, asthma) | BW | 90% | 84% |
| Schramm M 6 | 2011 | 179 patients with suspected lung cancer | BW/BB/TBNA | 79.0% | 98.2% |
| Tao W 30 | 2016 | 216 lung cancer patients, 209 benign lung diseases patients | BALF/BB | 69.2% | 100% |
| Shi A 23 | 2018 | 386 suspected lung cancer patients | BALF | 69.05% | 80.28% |
Abbreviations: BALF, bronchial alveolar lavage fluid; BB, bronchial brushing; BW, bronchial washing; TBNA, transbronchial needle aspiration.